NASDAQ:MDGS

Xylo Technologies (MDGS) Stock Price, News & Analysis

$2.36
+0.18 (+8.26%)
(As of 04/17/2024)
Today's Range
$2.17
$2.58
50-Day Range
$2.18
$3.05
52-Week Range
$2.11
$7.17
Volume
28,800 shs
Average Volume
9,658 shs
Market Capitalization
$3.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MDGS stock logo

About Xylo Technologies Stock (NASDAQ:MDGS)

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

MDGS Stock Price History

MDGS Stock News Headlines

The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Medigus Ltd ADR MDGS
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Medigus Ltd. (MDGS)
Medigus Goes a-Buyin’, Stocks Skid
Medigus Ltd.
Medigus GAAP EPS of -$0.33, revenue of $53.39M
See More Headlines
Receive MDGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xylo Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/30/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:MDGS
Employees
77
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$91.86 million
Book Value
$51.82 per share

Miscellaneous

Free Float
1,622,000
Market Cap
$3.92 million
Optionable
Optionable
Beta
0.31
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Liron Carmel (Age 39)
    Chief Executive Officer
    Comp: $318k
  • Ms. Tali Dinar (Age 53)
    Chief Financial Officer
    Comp: $172k
  • Dr. Yaron Silberman (Age 54)
    Chief Executive Officer of ScoutCam Ltd.
    Comp: $172k
  • Ilan Oren
    Executive Officer

MDGS Stock Analysis - Frequently Asked Questions

Should I buy or sell Xylo Technologies stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Xylo Technologies in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MDGS shares.
View MDGS analyst ratings
or view top-rated stocks.

How have MDGS shares performed in 2024?

Xylo Technologies' stock was trading at $3.26 at the beginning of 2024. Since then, MDGS shares have decreased by 27.6% and is now trading at $2.36.
View the best growth stocks for 2024 here
.

Are investors shorting Xylo Technologies?

Xylo Technologies saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 4,200 shares, a decrease of 17.6% from the March 15th total of 5,100 shares. Based on an average daily volume of 8,500 shares, the short-interest ratio is presently 0.5 days. Approximately 0.3% of the shares of the stock are sold short.
View Xylo Technologies' Short Interest
.

When is Xylo Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our MDGS earnings forecast
.

When did Xylo Technologies' stock split?

Xylo Technologies's stock reverse split before market open on Monday, November 14th 2022. The 1-15 reverse split was announced on Monday, November 14th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, November 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Xylo Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Xylo Technologies investors own include Bombardier (BDRBF), Advanced Micro Devices (AMD), Nuwellis (CHFS), Gevo (GEVO), Genius Brands International (GNUS), IntelGenx Technologies (IGXT), Inseego (INSG), Miragen Therapeutics (MGEN) and Naked Brand Group (NAKD).

How do I buy shares of Xylo Technologies?

Shares of MDGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MDGS) was last updated on 4/30/2024 by MarketBeat.com Staff

From Our Partners